Five articles suggested by Yüksel Ürün
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. His dedication to patient care and research inspires positive change in the medical field.
He suggested following few must-read papers on X:
1.”Genomic sequencing identified hereditary cancer risks in 9% of patients after uninformative gene panels. However, most findings lacked evidence-based guidelines.”
Clinical Utility of Genomic Sequencing for Hereditary Cancer Syndromes: An Observational Cohort Study.
Authors: Salma Shickh, et al.
2.”SOLO3 Trial Update: Olaparib improved ORR & PFS vs. nonplatinum chemo in BRCA-mutated relapsed ovarian cancer. OS benefit seen in 2 prior chemo lines (HR: 0.83). BRCA reversion mutations may impact negative outcomes in ≥3 lines.”
Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival Results.
Authors: Giovanni Scambia, et al.
3.”ENGOT-OV41/ANITA Trial Update: Adding atezolizumab to platinum-based chemo + maintenance niraparib did not improve PFS or ORR in late-relapsing recurrent ovarian cancer.”
Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial.
Authors: Antonio González-Martín, et al.
4.”Liquid Biopsy & MRD: ctDNA-based MRD detection in solid tumors can predict relapse months before imaging. A new era of post-adjuvant therapies may eliminate MRD.”
Minimal residual disease as a target for liquid biopsy in patients with solid tumours.
Authors: Klaus Pantel, et al.
5.”A game-changer for tailoring treatment in high-risk cases.”
Use of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Nodal Staging in Prostate Cancer and Tailoring of Treatment: A Continuing Conundrum.
Authors: Johan Stranne, et al.
More posts featuring Yüksel Ürün.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023